MOUNTAIN VIEW, Calif.,
Oct. 27, 2016 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL) today announced that
Wellforce has selected the Company's medication management
automation and analytics solutions to ensure medication security
and safety at its hospitals. Wellforce, a health system founded in
2014 by Massachusetts-based Tufts
Medical Center and Lowell General Hospital, is committed to
innovation and leveraging new technologies to further improve
patient safety while maintaining lower healthcare costs.
Automated medication management helps verify that the right
patient receives the right medication at the right time, and it can
also help keep hospital and patient costs down by reducing
unaccounted for medications in the hospital. A recent study shows
medication spending in hospitals increased by 23.4 percent annually
from 2013 to 2015, making it more important than ever to ensure
medications are secure in the inpatient setting.1
Both hospitals will be updating their automated medication
distribution systems in the patient care areas. The goal is to
improve patient safety and streamline provider workflows in the
medication administration process. The facilities will also be
using Omnicell Analytics, a drug diversion analytics platform that
uses prescribing and medication administration data to help
proactively prevent and identify drug diversion in the
hospital.
"As we work together to evaluate how new solutions and
technologies will support our existing and future members of the
Wellforce network, patient safety will always be our central
focus," said Brooke Hynes, Wellforce
spokesperson. "By improving the security and safe handling of
medications on our hospital floors and quickly identifying any
issues, we are putting our patients first."
"We are excited about the opportunity to support Wellforce's
commitment to providing excellent care at lower costs, and are
inspired by the personalized level of care the system's hospitals
and physicians deliver to their patients," said J. Christopher Drew, president, North American
Automation and Analytics at Omnicell. "By leveraging the
collaborative nature of a health system while focusing on their
unique patient needs, these facilities have demonstrated that they
are doing everything they can to provide the highest level of
care."
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired
to create safer and more efficient ways to manage medications and
supplies across all care settings. As a leader in medication and
supply dispensing automation, central pharmacy automation, IV
robotics, analytics software, and medication adherence and
packaging systems, Omnicell is focused on improving care across the
entire healthcare continuum—from the acute care hospital setting,
to post-acute skilled nursing and long-term care facilities, to the
patient's home.
Over 4,000 customers worldwide use Omnicell automation and
analytics solutions to increase operational efficiency, reduce
medication errors, deliver actionable intelligence and improve
patient safety. The recent acquisition of Aesynt adds distinct
capabilities, particularly in central pharmacy and IV robotics,
creating the broadest medication management product portfolio in
the industry.
The Omnicell SureMed solution provides innovative medication
adherence packaging to help reduce costly hospital readmissions.
These medication adherence solutions are used by over 17,000
institutional and retail pharmacies in North America and the United Kingdom.
These pharmacies are served via the Company's sales channels and
our solutions enable them to maintain high accuracy and quality
standards in medication dispensing and administration while
optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please
visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external website,
omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks
of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
1 American Hospital Association (2016). Hospital
Data Show Skyrocketing Drug Prices.
http://www.aha.org/presscenter/pressrel/2016/161011-pr-drugpricing.shtml
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/wellforce-selects-omnicells-medication-management-automation-and-diversion-prevention-solutions-300352463.html
SOURCE Omnicell, Inc.